BioCast - Film and TV Extras Louisiana, Promotional Work Louisiana, Events Work Louisiana, Directory Services, Free Postings for Agents and Directors.
|
|
10 studies recruit in and from this area KEYWORDS : TV Extras, Extras, Film Extras, Film and TV Extras Directories, Free Film and TV Extras Directries, Casting Agents, Extra Work, Supporting Artists, Events Work, Promotional Work, Promotional Staff, Screen Extras, Film Extra, Movie Extras, Film and TV Extras, Extras Agents, Acting, Actors, Acting Agencies, Stunt Men, Make Up Artists, Stage Design, Stage Hands, Theatrical Agents, Acting Schools, Set Designers, Art Directors, TV Productions, TV Directors, Film Directors, Model Agents, Talent Scouts.
IMPORTANT INFORMATION
You can participate in any of these activities between medical trials, clinical trials or at anytime . You can just participate in these activities alone if you wish . Why not combine these activities with the activities listed in our Mystery shopping or Non -Invasive research section, or with opportunities listed in our medical clinical trials section without any complications which could jeopardise your safety.
No expressed guarantees can be made as we are not the companies recruiting, but a lot of time effort and expense has been made to ensure these companies are of a reputable or acceptable standard in order to protect your better interests.
DON"T FORGET TO VIEW ALL THE OPPORTUNITIES PRESENTED FOR HEALTHY AND PATIENT VOLUNTEERS BY CLICKING STUDIES ON THE MENU BAR AND SELECTING YOUR GEOGRAPHICAL AREA . IF YOU ARE CONSIDERING HELPING MEDICAL RESEARCH AS A RESULT OUR WEB SITE, PLEASE BE AWARE YOU MUST BE OVER 18 TO PARTICIPATE IN BIOTRAX MEDICAL RESEARCH ACTIVITIES .
IF YOU ARE INTERESTED IN MEDICAL TRIALS AND WOULD LIKE TO TEST YOUR ELIGIBILITY CLICK ON ELIGIBILITY ON THE MENU BAR
HAPPY DAYS - WELL WISHES - BIOTRAX - THE RESEARCH VOLUNTEER SUPPORT GROUP - YOUR ONE STOP SHOP
ADVERTISERS IN THIS SECTION WITH THE EXCEPTION OF PRIORITY LOGO BRANDED INFORMATION STUDY BOXES ARE PROVIDED FREE OF CHARGE TO MYSTERY SHOPPING GROUPS AND AIDS TOWARDS VOLUNTEERS SATISAFACTION OF OUR FREE VOLUNTEER SERVICES.
Study 1277 :ARE YOU SUFFERING FROM DRUG-INDUCED TARDIVE DYSKINESIA - Houston only Texas
|
|
|
Type of Study | Interventional | Aim of Study | Have you ever taken an anti-psychotic medication or Reglan and developed uncontrolled muscle movements? You may qualify for a research study at Baylor College of Medicine. | Inclusion Criteria | You must be between 18 and 75 years of age and have uncontrolled muscle movements for at least 3 months. | Exclusion Criteria | Should not less than 18 years | Area | Houston
TX | Duration | Not Given | Reimbursement | Will be compensate for time and travel | Free Gift | Not Given | Other Info | Study Id :1745 | Notes | we need participants from Houston only |
|
Study 481 :Need healthy participants in New York for Kappa Opioid Receptor Imaging in PTSD New York
|
|
|
Type of Study | We are looking for healthy participants who are medically healthy and NOT currently taking medications. Eligible participants will receive compensation for their time.
| Aim of Study | Need healthy participants in New York for Kappa Opioid Receptor Imaging in PTSD
Therapeutic Area: Psychiatry/Psychology
Medical Condition(s): Healthy control subjects
| Inclusion Criteria | We are looking for subjects who:
Are medically healthy
Have not been treated for a psychological condition in the past or current
Are not taking any medications
Are 18-55 years of age
| Exclusion Criteria | The following subjects will be excluded from the study:
Pregnant or nursing
Subjects with an unstable medical condition or illness
Subjects currently taking recreational drugs or abusing alcohol
| Area | New York | Duration | n/a | Reimbursement | Eligible participants will receive compensation for their time. | Notes | Center Contact Information
Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name: Jordan Seidel
Title: Research Coordinator
|
|
Study 480 :Volunteers Need in at NYU - Kappa Opioid Receptor Imaging in Anorexia New York
|
|
|
Type of Study | We are looking for healthy participants who are medically healthy and NOT currently taking medications. Eligible participants will receive compensation for their time. | Aim of Study | Urgently Volunteers Need in at NYU - Kappa Opioid Receptor Imaging in Anorexia
Therapeutic Area: Psychiatry/Psychology
Medical Condition(s): Healthy control subjects
| Inclusion Criteria | We are looking for subjects who:
Are medically healthy
Have not been treated for a psychological condition in the past or current
Are not taking any medications
Are 18-55 years of age
| Exclusion Criteria | The following subjects will be excluded from the study:
Pregnant or nursing
Subjects with an unstable medical condition or illness
Subjects currently taking recreational drugs or abusing alcohol
| Area | New York | Duration | n/a | Reimbursement | Eligible participants will receive compensation for their time. | Notes | Center Contact Information
Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name: Jordan Seidel
Title: Research Coordinator
|
|
Study 560 :Functional Brain Imaging in PTSD New York
|
|
|
Type of Study | Psychiatry/Psychology
We are looking for participants suffering from posttraumatic stress disorder (PTSD) who are NOT currently taking medication. Eligible participants will receive compensation for their time. This study does NOT provide treatment. | Aim of Study | Posttraumatic Stress Disorder | Inclusion Criteria | We are looking for subjects who:
Have experienced a traumatic event (i.e., serious accident, natural disaster, violent crime, sexual assault or rape, being in a military war zone or combat)
Are not taking any psychiatric medications
Are 18-55 years of age | Exclusion Criteria | The following subjects will be excluded from the study:
Pregnant or nursing
Subjects with an unstable medical condition or illness
Subjects currently taking recreational drugs or abusing alcohol | Area | New York | Duration | not given | Reimbursement | please contact us so we can discuss further | Other Info | Contact Name: Jordan Seidel
Title: Research Coordinator
Address: New York University School of Medicine, One Park Avenue, 8th Floor, Room 8-227, New York, NY 10016, United States |
|
Study 1157 :Kappa Opiate Receptor Imaging in PTSD New York
|
|
|
Type of Study | Therapeutic Area: Psychiatry/Psychology
Medical Condition(s): Posttraumatic Stress Disorder | Aim of Study | We are looking for participants suffering from posttraumatic stress disorder (PTSD) who are NOT currently taking medication. Eligible participants will receive compensation for their time. This study does NOT provide treatment. | Inclusion Criteria | We are looking for subjects who:
Have experienced a traumatic event (i.e., serious accident, natural disaster, violent crime, sexual assault or rape, being in a military war zone or combat)
Are not taking any psychiatric medications
Are 18-55 years of age
| Exclusion Criteria | The following subjects will be excluded from the study:
Pregnant or nursing
Subjects with an unstable medical condition or illness (besides depression)
Subjects currently taking recreational drugs or abusing alcohol | Area | New York, NYC | Duration | not given | Reimbursement | please contact us to discuss further. | Other Info | Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name:Jordan Seidel
Title:Research Coordinator
Address: New York University School of Medicine, One Park Avenue, 8th Floor, Room 8-227, New York, NY 10016, United States |
|
Study 490 :Need participants suffering from depression in New York - KOR Depression New York
|
|
|
Type of Study | We are looking for participants suffering from depression who are NOT currently taking medication. Eligible participants will receive compensation for their time. | Aim of Study | Urgently need participants suffering from depression in New York - KOR Depression
Therapeutic Area: Psychiatry/Psychology
Medical Condition(s): Depression
| Inclusion Criteria | We are looking for subjects who:
Are experiencing symptoms of depression and anxiety
Are not taking any psychiatric medications
Are 18-55 years of age
| Exclusion Criteria | The following subjects will be excluded from the study:
Pregnant or nursing
Subjects with an unstable medical condition or illness (besides depression)
Subjects currently taking recreational drugs or abusing alcohol
| Area | New York | Duration | N/a | Reimbursement | Eligible participants will receive compensation for their time. | Other Info | Study Number: S14-00643 | Notes | Center Contact Information
Center Name: Molecular Imaging Program in Anxiety and Mood Disorders at NYU
Contact Name: Jordan Seidel
Title: Research Coordinator
|
|
Study 1278 :Get $1,575 - STUDY TO ASSESS EFFECTS OF PF-04457845 ON BOLD FUNCTIONAL MRI IN SUBJECTS WITH PTSD New York
|
|
|
Type of Study | BOLD FUNCTIONAL MRI IN SUBJECTS WITH PTSD | Aim of Study | PF-04457845 is a fatty acid amide hydrolase (FAAH) inhibitor. FAAH is responsible for hydrolyzing the fatty acid amide, anandamide (AEA). Stress induces increases in FAAH activity which result in decreased brain levels of the endocannabinoid (eCB), AEA and reduced signaling via cannabinoid type 1 receptors (CB1). Deficits in eCB signaling may play a key role in the etiology of PTSD and may mediate important components of the PTSD phenotype.
Our hypothesis is that the increase in brain AEA levels achieved by inhibition of FAAH will restore signaling through CB1 in a regionally specific manner and thus alleviate the effects of stress.
| Inclusion Criteria | 1. Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study.
2. Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures.
3. Male and female subjects of childbearing potential and at risk for pregnancy must agree to use of a highly effective method of contraception throughout the study and for at least the 28 days after the last dose of assigned treatment.
4. Female subjects of non-childbearing potential must meet at least one of the following criteria:
a. Have undergone a documented hysterectomy and/or bilateral oophorectomy.
b. Have medically confirmed ovarian failure.
c. Achieved postmenopausal status, defined as follows: cessation of regular menses for at least 12 consecutive months with no alternative pathological or physiological cause; status may be confirmed by having a serum follicle-stimulating hormone (FSH) level within the laboratorys reference range for postmenopausal women.
All other female subjects (including females with tubal ligations and females that do
NOT have a documented hysterectomy, bilateral oophorectomy and/or ovarian failure) will be considered to be of childbearing potential.
5. Healthy male and/or female subjects between the ages of 18 and 60 years, inclusive.
Healthy is defined as no clinically relevant abnormalities identified by a detailed medical history, full physical examination, including blood pressure and pulse rate measurement, 12-lead ECG and clinical laboratory tests.
6. Body Mass Index (BMI) of 17.5 to 32 kg/m2; and a total body weight _50 kg (110 lbs).
7. Subjects who are right handed.
8. Subjects who can read, speak, and comprehend English.
9. Subjects must be outpatients with a primary diagnosis of PTSD (DSM-V criteria 309.81). Symptom severity must be such that subjects have a Clinician-administered CAPS (_35) and CGI-S score (_3) at both Screening and Day 1 (baseline) visits to qualify for clinical trial entry.
PTSD must be the primary psychiatric disorder present (confirmed by Structured Clinical Interview for DSM IV research version patient edition (SCID-RV/P) and the condition that motivated the subject to seek treatment.
Subjects with concurrent diagnoses of MDD, which is no more than moderate in severity, dysthymic disorder, generalized anxiety disorder, specific phobia, or social phobia, are eligible, if PTSD is the primary diagnosis and the subject is not currently requiring psychopharmacological intervention for these conditions. | Exclusion Criteria | Who do not match above requirments | Area | New York | Duration | 28 days | Reimbursement | Subjects will receive $1,575 for being in this study. | Other Info | Study Coordinator: Jordan Seidel, MA; Jordan.Seidel@nyumc.org; 646-754-4829 |
|
|